This is an increase of 3 respondents from the currently approved estimate of 27 in the CY 2024 PFS final rule (88 FR 79430)
The consequences of stunting persist beyond childhood, affecting both physical health and cognitive development
[7] 2015: Copenhagen Wintergreen Packs, a more pliable and softer version of Copenhagen Wintergreen Pouches is released nationwide
Said differently, to identify the payment amount benchmark period for the purpose of calculating the benchmark period manufacturer price for a Part D rebatable drug first approved or licensed on or before October 1, 2021, CMS would first look to the period from January 1, 2021, to September 30, 2021 and if no AMP was reported to the MDRP for that 3-quarter period, CMS would then identify the payment amount benchmark period as the first calendar year no earlier than calendar year 2021 in which such drug has at least 1 quarter of AMP reported
the patient's requirements for education, vocational rehabilitation, and employment